Skip to content

Raymed Labs Ltd

  • Home
  • Investor Desk
  • Contact US
  • Home
  • Investor Desk
  • Contact US

SEBI (Other) Disclosures

Home/Investor Desk/SEBI (Other) Disclosures

Year 2024

  • Voting Result and Scrutinizer Report
  • Reg 31 (4) 2024
  • Large Corporate undertaking_March, 2024

Year 2023

  • Intimation under Reg 30(5)
  • Scrutinizer Report 2022-23
  • Reg 31 (4) 2023
  • Large Corporate undertaking_March, 2023

Year 2022

  • Declaration_under_Reg_31(4)
  • Large Corporate undertaking_March, 2022

Year 2021

  • Reg_30_2021
  • Reg_31 (4) 2021
  • Undertaking March 2021

Year 2020

  • Reg_30(2)- March 2020
  • Declaration_for_Non_applicability_of_large_Company

Year 2019

  • Disclosure under Regulation 30(1) & 30(2)_March 2019
  • SEBI Notice (Disclosure)

SH-13 AND SH-14 NOMINATION

  • ISR-1: Request for Registering Pan, KYC Details or Changes / Updation Thereof
  • ISR-2: Confirmation of Signature of Securities Holder by the Banker
  • ISR-3: Declaration Form For Opting-Out of Nomination by Holders of Physical Securities in Listed Companies
Theme by Think Up Themes Ltd. Powered by WordPress.